SCLC ClinicalImpact: New Tools and Expert Guidance for Integrating Immunotherapies

Get expert insights on the optimal integration of immunotherapies in the treatment of small-cell lung cancer with expert-authored commentaries, a series of 10 brief interactive videos with downloadable slidesets, and a new Interactive Decision Support Tool with expert recommendations individualized to your specific patient scenarios.
Taofeek K. Owonikoko, MD, PhD

ClinicalThought

Read my thoughts on the importance of using combination chemoimmunotherapy as first-line treatment for extensive-stage SCLC.

Taofeek K. Owonikoko, MD, PhD Released: October 13, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
AstraZeneca
Merck Sharp & Dohme Corp.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue